Figures & data
FIG. 1 Left panel: B6C3F1 female mice were sensitized intravenously (IV) with SRBC and evaluated on Day 4 in the Plaque Assay. Data are presented as specific activity (IgM AFC/106 spleen cells) or total spleen activity (IgM AFC/spleen). Middle panel: Animals were sensitized IV with 100 μ g/animal of KLH and serum collected on Day 5. Serum levels of IgM anti-KLH antibody were determined by ELISA. Right panel: Animals were sensitized IV with 2 mg/animal of KLH and serum collected on Day 5. Serum levels of IgM anti-KLH antibody were determined by ELISA. Results are expressed as percent of vehicle control. *p ≤ 0.05 or **p ≤ 0.01 vs. vehicle treated animals. Each group consisted of eight animals.
![FIG. 1 Left panel: B6C3F1 female mice were sensitized intravenously (IV) with SRBC and evaluated on Day 4 in the Plaque Assay. Data are presented as specific activity (IgM AFC/106 spleen cells) or total spleen activity (IgM AFC/spleen). Middle panel: Animals were sensitized IV with 100 μ g/animal of KLH and serum collected on Day 5. Serum levels of IgM anti-KLH antibody were determined by ELISA. Right panel: Animals were sensitized IV with 2 mg/animal of KLH and serum collected on Day 5. Serum levels of IgM anti-KLH antibody were determined by ELISA. Results are expressed as percent of vehicle control. *p ≤ 0.05 or **p ≤ 0.01 vs. vehicle treated animals. Each group consisted of eight animals.](/cms/asset/b5dc3691-46d4-48c5-9d5f-ab459609cbc4/iimt_a_233662_uf0001_b.gif)
FIG. 2 Left panel: Sprague–Dawley (SD) female rats were sensitized with SRBC and evaluated on Day 4 in the Plaque Assay. Data are presented as specific activity (IgM AFC/106 spleen cells). Middle panel: Animals were sensitized IV with 100 μ g/animal of KLH and serum collected on Day 6. Serum levels of IgM anti-KLH antibody were determined by ELISA. Right panel: Animals were sensitized IV with 2 mg/animal of KLH and serum collected on Day 6. Serum levels of IgM anti-KLH antibody were determined by ELISA. Results are expressed as percent of vehicle control. *p ≤ 0.05 or **p ≤ 0.01 vs. vehicle-treated animals. Each group consisted of 7–8 animals.
![FIG. 2 Left panel: Sprague–Dawley (SD) female rats were sensitized with SRBC and evaluated on Day 4 in the Plaque Assay. Data are presented as specific activity (IgM AFC/106 spleen cells). Middle panel: Animals were sensitized IV with 100 μ g/animal of KLH and serum collected on Day 6. Serum levels of IgM anti-KLH antibody were determined by ELISA. Right panel: Animals were sensitized IV with 2 mg/animal of KLH and serum collected on Day 6. Serum levels of IgM anti-KLH antibody were determined by ELISA. Results are expressed as percent of vehicle control. *p ≤ 0.05 or **p ≤ 0.01 vs. vehicle-treated animals. Each group consisted of 7–8 animals.](/cms/asset/f100a52c-90eb-491a-b978-c3f04ea2d029/iimt_a_233662_uf0002_b.gif)